Clinical Trial

Pharmacy-based Provision of Pre-exposure Prophylaxis (PrEP) for Adolescent Girls and Young Women in Tanzania

Study acronym: MWOTAJI
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Implementation study comparing standard pre-exposure prophylaxis (PrEP) services to four models of pharmacy-based PrEP access for young women aged 18-24 (YW) in Tanzania. At 9 months, all sites converge to one pharmacy-based PrEP model and are randomly allocated to one of two cost sharing models to increase the program's potential for sustainability.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-30.
Trial Details
NCT Number NCT07687888
Lead Sponsor Mzumbe University - Centre of Excellence in Health Monitoring and Evaluation
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of California, Berkeley, University of California, San Francisco
Conditions HIV, PrEP
Enrollment 2,818 participants
Start Date 2026-09
Primary Completion 2028-02 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-22